Amarantus Bioscience Holdings Inc (AMBS)

[newflow]

Eltoprazine Phase-111 AND Human Skin Replacement

Active Indications (Highest Phase)

Phase III
Attention-deficit hyperactivity disorder
Phase II
Aggression; Drug-induced dyskinesia

Most Recent Events

13 Sep 2016
Phase-III clinical trials in Attention-deficit hyperactivity disorder (PO) (Amarantus BioScience pipeline, September 2016)
10 Feb 2016
Eltoprazine receives Orphan Drug status for Drug-induced dyskinesia in patients with Parkinson's disease in USA
04 Jan 2016
Amarantus pauses enrolment in its phase IIb trial for Drug induced dyskinesia in USA
---------------------
Tissue replacements
Active Indications (Highest Phase)

Phase II
Burns
Clinical Phase Unknown
Nevus


Most Recent Events

13 Sep 2016
Phase-II clinical trials in Burns in USA (Topical)
08 Aug 2016
Clinical trials in Burns (In children) in USA (Topical) prior to August 2016
08 Aug 2016
Positive efficacy data from a compassionate use clinical trial in Burns released by Amarantus BioScience

http://adisinsight.springer.com/search